Screening new drugs with stem cells

Mass producing stem cells to screen drugs and study the progress of disease is not the sexier side of the field.  But it’s getting more attention now–and it’s about time.

View the original article here: Screening New Drugs With Stem Cells – Forbes

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend